Beverly Hills Cancer Center

Summary

Beverly Hills Cancer Center is a medical facility located in Beverly Hills, California. This center is recognized for care of Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Cancer, Pancreatic Cancer and other specialties. Beverly Hills Cancer Center is involved with conducting 53 clinical trials across 59 conditions. There are 4 research doctors associated with this hospital, such as David Berz, Ali Muhammad, MD, MBA, Linnea Chap, MD, and Eli Gabayan.

Top PIs

Clinical Trials running at Beverly Hills Cancer Center

Breast Cancer

Lung Cancer

Multiple Myeloma

Cancer

Non-Small Cell Lung Cancer

Liver Cancer

Tumors

Cachexia

Ovarian Cancer

Endometrial Cancer

RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant

for Breast Cancer

This is a global, multicenter, open-label, randomized Phase 3 study comparing the efficacy and safety of RLY-2608 + fulvestrant to capivasertib + fulvestrant for the treatment of patients with HR+/HER2- ABC with PIK3CA mutation following recurrence or progression on or after treatment with a CDK4/6 inhibitor.

Recruiting

2 awards

Phase 3

5 criteria

BNT327 + Chemotherapy

for Breast Cancer

This study is a Phase II, multi-site, randomized, open-label clinical study to evaluate the safety, efficacy, and pharmacokinetics (PK) of BNT327 at two dose levels in combination with chemotherapeutic agents in the first- and second-line treatment of participants with locally advanced/metastatic triple-negative breast cancer (mTNBC).

Recruiting

1 award

Phase 2

4 criteria

BL-B01D1

for Lung Cancer

The objective of this study is to evaluate the safety, tolerability, and efficacy of BL-B01D1 in patients with Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors.

Recruiting

1 award

Phase 1

7 criteria